A generic version of a drug that’s “as close as we’ve ever been to an HIV vaccine” could be made for $40 a year per patient (with a 30% profit). Current pricing by Gilead: $42,250 per year.
Advertise here with Carbon Ads
This site is made possible by member support. ❤️
Big thanks to Arcustech for hosting the site and offering amazing tech support.
When you buy through links on kottke.org, I may earn an affiliate commission. Thanks for supporting the site!
kottke.org. home of fine hypertext products since 1998.
Discussion 2 comments
If I recall correctly, Gilead had nothing to do with the development of this drug and simply bought the patent. They are cartoon villains and we are long overdue for a more affordable solution.
I'm tempted to ask how people sleep at night, knowing that they chose massive profits over saving lives. But I realize the answer is that they sleep just fine. If they can't summon the basic humanity to make this drug affordable to all who need it, then someone needs to make that decision for them
Hello! In order to leave a comment, you need to be a current kottke.org member. If you'd like to sign up for a membership to support the site and join the conversation, you can explore your options here.
Existing members can sign in here. If you're a former member, you can renew your membership.
Note: If you are a member and tried to log in, it didn't work, and now you're stuck in a neverending login loop of death, try disabling any ad blockers or extensions that you have installed on your browser...sometimes they can interfere with the Memberful links. Still having trouble? Email me!
In order to leave a comment, you need to be a current kottke.org member. Check out your options for renewal.
This is the name that'll be displayed next to comments you make on kottke.org; your email will not be displayed publicly. I'd encourage you to use your real name (or at least your first name and last initial) but you can also pick something that you go by when you participate in communities online. Choose something durable and reasonably unique (not "Me" or "anon"). Please don't change this often. No impersonation..
Note: I'm letting folks change their display names because the membership service that kottke.org uses collects full names and I thought some people might not want their names displayed publicly here. If it gets abused, I might disable this feature.
If you feel like this comment goes against the grain of the community guidelines or is otherwise inappropriate, please let me know and I will take a look at it.
Hello! In order to leave a comment, you need to be a current kottke.org member. If you'd like to sign up for a membership to support the site and join the conversation, you can explore your options here.
Existing members can sign in here. If you're a former member, you can renew your membership.
Note: If you are a member and tried to log in, it didn't work, and now you're stuck in a neverending login loop of death, try disabling any ad blockers or extensions that you have installed on your browser...sometimes they can interfere with the Memberful links. Still having trouble? Email me!